Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Johnson and Johnson
Colorcon
Mallinckrodt
McKinsey

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Isavuconazole

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Isavuconazole?

Isavuconazole is an investigational drug.

There have been 35 clinical trials for Isavuconazole. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2018.

The most common disease conditions in clinical trials are Mycoses, Aspergillosis, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Basilea Pharmaceutica International Ltd, Astellas Pharma Global Development, Inc., and Astellas Pharma Inc.

There are eighteen US patents protecting this investigational drug and two hundred and forty international patents.

Recent Clinical Trials for Isavuconazole
TitleSponsorPhase
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy ParticipantsAstellas Pharma Global Development, Inc.Phase 1
A Study of Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)National Cancer Institute (NCI)Phase 2
Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant RecipientsVeloxis PharmaceuticalsPhase 4

See all Isavuconazole clinical trials

Clinical Trial Summary for Isavuconazole

Top disease conditions for Isavuconazole
Top clinical trial sponsors for Isavuconazole

See all Isavuconazole clinical trials

US Patents for Isavuconazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Isavuconazole   Start Trial Azoles for treatment of fungal infections Basilea Pharmaceutica AG, a Swiss Company (Basel, CH)   Start Trial
Isavuconazole   Start Trial N-substituted carbamoyloxyalkyl-azolium derivatives Basilea Pharmaceutica AG (Binningen, CH)   Start Trial
Isavuconazole   Start Trial Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives Basilea Pharmaceutica AG (Basel, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
Colorcon
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.